Tirzepatide

Yes. Tirzepatide is used in FDA-approved medications. Mounjaro® is approved for eligible patients with type 2 diabetes, while Zepbound® is approved for chronic weight management in qualifying patients and for certain adults with obesity and moderate-to-severe obstructive sleep apnea.

Semaglutide works on the GLP-1 receptor. Tirzepatide works on both GIP and GLP-1 receptors, so the two medications act through different metabolic pathways.

One medication is not automatically the best choice for everyone. Your provider will consider your health history, treatment goals, previous response, tolerability, and insurance coverage.

FDA-approved tirzepatide treatment generally begins at 2.5 mg once weekly for 4 weeks, followed by 5 mg once weekly. If more treatment effect is needed and the medication is well tolerated, the dose may be increased gradually.

The commonly referenced sequence is 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg once weekly. Your individual dosing plan may differ.

No. The dose ladder is a guide, not a goal.

If your current dose is working well and you are tolerating it comfortably, your provider may recommend staying at that dose rather than automatically increasing it.

Some patients notice changes in appetite or fullness during the first several weeks. Changes in weight and body composition usually develop more gradually.

Everyone responds differently, which is why follow-up and individualized dosing are important.

Results vary based on starting weight, dose, treatment duration, nutrition, physical activity, metabolic health, adherence, and individual response.

At Alpha Hormones®, we also look beyond the number on the scale by monitoring body fat, lean muscle, visceral fat, waist measurements, and metabolic markers when appropriate.

Any significant weight loss can include some loss of lean mass as well as body fat, so preserving muscle is an important part of a well-managed weight-loss program.

Adequate protein, resistance training, appropriate nutrition, and body-composition monitoring can help support lean muscle during treatment.

Common side effects may include nausea, reduced appetite, diarrhea, constipation, vomiting, abdominal discomfort, indigestion, or reflux. These can be more noticeable when starting treatment or increasing the dose.

Less common but more serious risks can also occur. Your provider will review the risks that are most relevant to your medical history before treatment.

In some patients, hormone therapy and tirzepatide can be part of the same overall treatment plan when each treatment is medically appropriate.

Your provider will review your hormone treatment, laboratory results, medications, metabolic health, and weight-management goals before making a recommendation.

Yes. Alpha Hormones® takes a comprehensive approach to medical weight management rather than focusing only on medication.

Depending on your symptoms and history, your evaluation may include thyroid function, hormones, insulin resistance, blood sugar, lipids, medications, sleep, nutrition, physical activity, stress, and body composition.

Tirzepatide is only one of several medical weight-management options. Your provider may discuss semaglutide, phentermine, Qsymia®, Contrave®, other prescription options, nutrition and lifestyle strategies, or treatment of underlying metabolic or hormonal factors.

The goal is to choose the treatment strategy that makes the most sense for your health and goals.

Compounded tirzepatide may be discussed when legally permitted and clinically appropriate for an individual patient.

Eligible compounded treatment starts at $249 per month, with medical management included and no required monthly membership.

Pricing may vary based on the prescribed dose, pharmacy, shipping, and supplies. Compounded tirzepatide is not FDA-approved and is different from Zepbound® and Mounjaro®.

Yes. Our team can review your insurance benefits and see whether an appropriate FDA-approved tirzepatide medication may be covered by your plan.

If prior authorization is required, we can help submit the relevant clinical information and supporting documentation.

Coverage varies by plan and approval is not guaranteed, but we can help you understand the process and your available options.

Tirzepatide is generally not used together with another tirzepatide-containing product or another GLP-1 medication such as semaglutide. Your provider can help you safely transition between treatments when appropriate.

Appetite and weight can increase again after stopping treatment, especially if the factors that contributed to weight gain are still present.

Your provider can help you build a longer-term maintenance strategy using nutrition, resistance training, activity, metabolic or hormonal treatment when appropriate, and ongoing follow-up.

Eligible medical consultations, laboratory testing, and prescribed medications may qualify for HSA or FSA payment. Check with your plan administrator for the rules that apply to your specific account.

Our approach goes beyond simply prescribing a medication. We evaluate metabolic health, hormones when appropriate, current medications, nutrition, physical activity, body composition, and other factors that may influence your weight.

We also offer multiple medication options, individualized dosing, insurance and prior authorization support, flexible self-pay options, and ongoing medical monitoring as your treatment plan evolves.